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Abstract
Assessment of exposure to malaria vectors is important to our understanding of spatial and temporal variations in disease
transmission and facilitates the targeting and evaluation of control efforts. Recently, an immunogenic Anopheles gambiae
salivary protein (gSG6) was identified and proposed as the basis of an immuno-assay determining exposure to Afrotropical
malaria vectors. In the present study, IgG responses to gSG6 and 6 malaria antigens (CSP, AMA-1, MSP-1, MSP-3, GLURP R1,
and GLURP R2) were compared to Anopheles exposure and malaria incidence in a cohort of children from Korogwe district,
Tanzania, an area of moderate and heterogeneous malaria transmission. Anti-gSG6 responses above the threshold for
seropositivity were detected in 15% (96/636) of the children, and were positively associated with geographical variations in
Anopheles exposure (OR 1.25, CI 1.01–1.54, p=0.04). Additionally, IgG responses to gSG6 in individual children showed
a strong positive association with household level mosquito exposure. IgG levels for all antigens except AMA-1 were
associated with the frequency of malaria episodes following sampling. gSG6 seropositivity was strongly positively
associated with subsequent malaria incidence (test for trend p=0.004), comparable to malaria antigens MSP-1 and GLURP
R2. Our results show that the gSG6 assay is sensitive to micro-epidemiological variations in exposure to Anopheles
mosquitoes, and provides a correlate of malaria risk that is unrelated to immune protection. While the technique requires
further evaluation in a range of malaria endemic settings, our findings suggest that the gSG6 assay may have a role in the
evaluation and planning of targeted and preventative anti-malaria interventions.
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Introduction
Heterogeneity in malaria exposure is present at all levels of
endemicity [1] but is most readily observed in areas of low
transmission and following periods of extensive control [1–3].
Recent evidence of decreasing malaria incidence [2,4], has fuelled
calls for malaria elimination from the world’s public health,
political and philanthropic authorities [5,6]. As a result the interest
in malaria heterogeneity and its potential effect on malaria control
has increased [2,3,7]. Hotspots of higher malaria transmission are
likely to hamper malaria elimination efforts, as residual foci of
persistent malaria infection may seed transmission to the wider
community [8–10].
Although not all factors that affect malaria heterogeneity are
fully understood, variation in the exposure to malaria vectors is
likely to be of key importance [3,11–13]. In sub-Saharan Africa,
the transmission of Plasmodium falciparum is maintained by three key
mosquito species; Anopheles gambiae, An. arabiensis and An. funestus
[14]. Mosquito exposure is typically assessed as a component of
the entomological inoculation rate (EIR), which is defined as the
number of infectious Anopheles bites per person per unit time (ib/p/
yr) [15,16]. Despite its value in malaria research, a direct
assessment of EIR to determine small-scale variation in malaria
exposure is operationally unattractive at low levels of transmission
(EIR,10 ib/p/yr) [17–19]. The development of accurate and
sensitive tools for identifying micro-epidemiological variations in
vector exposure and malaria risk is important in assessing the
efficiency of control efforts and focusing interventions to those
areas or populations that are most affected by malaria. Serological
assessments of malaria exposure are receiving increasing interest in
this respect and have been used for quantifying malaria trans-
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[11,22,23]. Recently, serological markers of malaria exposure
were also used to quantify heterogeneity in the efficacy of malaria
interventions [24]. Recombinant malaria blood stage antigens
have been most widely used for these purposes [25], while
responses to the infective sporozoite specific circum-sporozoite
protein (CSP) are currently viewed as the best available serological
tool to detect exposure to infectious mosquito bites [18,26–28]. A
similar tool to identify spatial patterns of cumulative exposure to
Anopheles biting could be integral to the detection of malaria
hotspots and play a role in forecasting the risk of malaria
epidemics or the dynamics of malaria resurgence in areas where
parasite carriage in human populations has decreased but
exposure to malaria vectors persists [29].
Our understanding of the human immune response to mosquito
saliva has until recently been largely restricted to culicine
mosquitoes and the clinical consequences of allergy [30–32].
Humoral responses to the saliva of various disease vectors have
been exploited epidemiologically, revealing significant correlation
with disease seropositivity and vector exposure. Such assays have
now been described for Ixodes ticks [33,34], triatomine bugs [35],
Glossina tsetse flies [36] and Lutzomyia and Phlebotomus sand flies
[37,38]. Recently, transcriptome analysis of the salivary glands of
An. gambiae females identified over 70 putative secreted salivary
proteins [39–41]. A small (,10 kb) immunogenic protein,
gambiae salivary gland protein 6 (gSG6), that is well conserved
in the three major Afrotropical malaria vectors (An. gambiae, An.
arabiensis and An. funestus) and restricted to anopheline mosquitoes
[42], has been identified as a suitable candidate for a bioassay of
Anopheles exposure [43,44]. Antibody responses to a gSG6 peptide
(gSG6-P1) described Anopheles exposure in areas of low vector
density [45] and in response to vector control programs [46] with
some success, and were recently shown to reflect Anopheles
heterogeneity at the district level in Dakar, Senegal [47].
Recombinant full length gSG6 has also shown strong immunoge-
nicity among rural populations in Burkina Faso, which appears to
be sufficiently short lived to correlate with seasonal changes in
Anopheles abundance [43,48].The relationship between malaria
case incidence and anti-gSG6 response has not been studied,
despite early indications that humoral responses to Anopheles whole
saliva were positively associated with malaria infection [49].
Using a subset of samples collected during a large study of
intermittent presumptive treatment among infants (IPTi) [50],
along with entomological data from an intensive survey in the
same area [11], we present the first evaluation of IgG antibody
responses to the recombinant gSG6 salivary antigen for describing
spatial heterogeneity in vector exposure between and within
geographically defined subvillages in an area of moderate and
heterogeneous malaria exposure in northern Tanzania. At the
individual level, we determine the association of gSG6 reactivity
with household Anopheles exposure and subsequent malaria in-
cidence. In addition, we determined reactivity against a selection
of malaria antigens that have been more commonly used in
epidemiological studies, namely CSP and four blood stage
proteins, AMA-1, MSP-1, MSP-3, and glutamate-rich protein
(GLURP).
Methods
Ethics Statement
Witnessed written consent was provided by the caregivers of all
children involved in serological sampling, and by heads of
households for participation in the entomological survey. Ethical
approval was granted by the review board of the National Institute
for Medical Research of Tanzania, and the London School of
Hygiene and Tropical Medicine ethics committee.
Study Area and Subjects
Plasma samples were collected from children recruited over 18
months as part of a longer-term study (2004–2008) carried out in
the district of Korogwe, Northern Tanzania, an area of moderate
malaria endemicity. Korogwe district is situated ,600 m above
sea level, and has a seasonal pattern of rainfall (800–1400 mm/
year) [50]. Malaria transmission in the Korogwe region has
declined in recent years [51], such that an EIR of 1–14 ib/p/yr
was estimated in 2007 [21]. The original study investigated the
relative impacts of different drug regimens for intermittent
presumptive treatment (IPTi) among a total of 1280 infants [50].
Entomological Data Collection
In the final year of the IPTi study a randomly selected subset of
600 children were enrolled in a detailed entomological survey,
aiming to describe spatial patterns of malaria incidence in relation
to mosquito exposure [11]. In the room of each selected child,
mosquitoes were sampled with miniature CDC light traps (Model
512; John W. Hock Company, Gainesville, Florida) for one night
at the end of the wet season (May), again at the beginning (July)
and finally the end (September) of the dry season in 2008.
Mosquito exposure at the household level was highly correlated
between all surveys (correlation coefficient: May/July=0.462,
May/September=0.497, July/September=0.444; p,0.0001).
Mosquito data from first of the three sampling points, during
the peak transmission season when Anopheles abundance was
highest, was therefore deemed adequate in displaying variation in
exposure. Of the total Anopheles females caught during sampling,
An. gambiae s.l. made up 80.3%, An. funestus 18.6% and other
anophelines 1%.
Clinical Data and Plasma Samples
Malaria incidence was assessed by passive monitoring for signs
of illness throughout the 22 months following recruitment, during
which time free access to clinical treatment was provided [50]. The
average age at recruitment was 9.4 weeks (range 8–17 weeks) and
infants were recruited at different times of the year, i.e. at different
time-points in the transmission season. Plasma samples used in the
current study were taken at 9 months of age when infants were
presented at clinics as part of the Expanded Program on
Immunisation (EPI). Blood samples were collected by finger prick
and after plasma separation samples were stored at 220uC until
processing. In our analyses, we included malaria incidence in the
period between serum collection at 9 months of age and the end of
follow-up. This gave an effective follow up period of approxi-
mately 15 months and ensured that the follow-up period included
one or more peak malaria transmission seasons for each child. The
current analyses are an ancillary study and many of the blood
samples had been used previously for other IPTi specific
investigations. As a result of this non-systematic exhaustion of
samples, sera were available for a subset of 636/1280 children for
gSG6 ELISA; 247/636 children from this subset were involved in
the household level entomological survey.
gSG6 ELISA
ELISA was performed as previously described with few
modifications [43,48]. Briefly, Maxisorp 96-well plates (Nunc
M9410) were coated with gSG6 at 5 ug/ml. Test and negative
control serum were analysed in duplicate at 1:100 in phosphate
buffered saline with 0.05% Tween 20 (PBST)/1% skimmed milk
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were included to correct sample ODs for background antibody
reactivity, and positive control sera (1:40 in PBST/Marvel) were
analysed to allow standardisation of OD values for day-to-day and
inter-plate variation. Positive control sera was provided, with
consent, by an employee of the London School of Hygiene and
Tropical medicine who was exposed weekly to the bites of
approximately 50–100 laboratory bred An. gambiae s.s (Kisumu
strain) during colony feeding.
Sera from 39 Europeans with no recent history of travel to
malaria endemic countries were used as negative controls for
calculation of IgG seroprevalence. Cut off for seropositivity among
samples was determined as the mean OD of the unexposed sera
plus 3 standard deviations.
P. falciparum ELISA and Luminex Assays
For this analysis, IgG antibody responses were chosen in
preference to IgM for their high antigen specificity. IgG antibody
responses against CSP (Gennova, 0.009 mg/ml), AMA-1 (BPRC,
0.3 mg/ml) and MSP-119 (CTK Biotech, 0.2 mg/ml) were detected
as previously described [20,27]. Test sera were analysed in
duplicate at 1:200 (CSP), 1:1000 (MSP-119) or 1:2000 (AMA-1) in
PBST/Marvel. Blank wells, positive control sera from a hyper-
endemic region in the Gambia [20], and a serial dilution of pooled
hyper-immune sera were included in duplicate on each plate to
correct for non-specific reactivity and allow standardisation of
inter-plate variation. Seroprevalence of IgG antibodies to these
non-salivary antigens was calculated using a mixture model as
described previously [20,52].
Recombinant proteins corresponding to the R1, R2 (Central
repeat and C-terminal repeat regions of GLURP), and the C-
terminal region of MSP-3 [53] were covalently coupled to
carboxylated luminex microspheres according to the manufac-
turer’s protocol and tested as previously described [54]. Cut-off for
positivity was calculated as the mean reactivity in malaria non-
exposed European individuals plus 2 standard deviations.
Data Analysis
To examine the relationship between patterns of gSG6
reactivity and small scale spatial variation in Anopheles exposure,
antibody responses were described at the level of subvillages,
which are defined by their geographical location (Figure 1) [11].
The arithmetic mean mosquito exposure for each village was used
for ranking villages from low to high mosquito exposure; this rank
was related to antibody prevalence and mean log 10 adjusted
antibody level per subvillage. This enabled analyses relating to
geographic variations in Anopheles abundance for all individuals,
irrespective of their involvement in the entomological survey
(Figure 2).
For infants for whom both household mosquito data and plasma
samples were available, it was possible to investigate associations
between Anopheles exposure and antibody reactivity against salivary
and malaria antigens at an individual level. For this purpose,
households were analysed in quintiles of Anopheles exposure
(Table 1).
Statistical analysis was conducted in STATA (Version 10,
STATA statistical software StataCorp) and GraphPad Prism
(Version 5.0, GraphPad Software Inc., La Jolla, CA) software
packages. IgG responses to salivary or malaria antigens between
two independent groups were compared by Wilcoxon rank-sum
tests (Mann-Whitney U test), with Bonferroni correction for
multiple comparisons between subgroups. Comparisons of multi-
ple groups were carried out by Kruskal-Wallis test. Seroprevalence
comparisons were made using Chi-square test, with a test for trend
in proportions. Correlations between IgG and malaria or
entomological measures were made using Spearman correlation
or with linear regression analysis after log10-transformation of OD
data. IPTi treatment arm was included in our analyses as potential
confounder. As a small number of sample ODs were lower than
their ELISA plate blank value, some normalised ODs had negative
values and an arbitrary positive value (+1) was therefore added to
all ODs before transformation.
Results
Small Scale Spatial Variation in Anopheles Exposure and
anti-gSG6 Responses
The recombinant gSG6 protein elicited significant anti-gSG6
IgG responses in children from Korogwe district (mean OD 0.109,
maximum OD 2.014). European sera were used as negative
controls for exposure to Anopheles mosquitoes, the responses of
which were pooled to determine a cut-off for seroprevalence at
OD 0.167 (Table 2). Mean OD among antibody negative children
from Korogwe was 0.052, and ranged from 0.001–0.166 (standard
deviation 0.040). IPTi treatment arm was not associated with
gSG6 antibody prevalence (p=0.23) or density (p=0.38) and did
not show any evident association with any of the other antigens
tested, nor was it found to be a confounder in any of the
associations presented below (data not shown).
When mean mosquito exposure was plotted against log 10
adjusted anti-gSG6 IgG level for each of the 15 subvillages,
a significant positive association was observed between mean
mosquito exposure and antibody reactivity (Figure 3). Similarly,
despite significant variability in gSG6 response between sub-
villages, there was a significant positive association between mean
mosquito exposure per subvillage and anti-gSG6 IgG seropositiv-
ity, wherein an average increased exposure of 10 mosquitoes was
associated with a 25% increase in antibody positivity (odds ratio
[OR] 1.25, CI 1.01–1.54, p=0.04).
Household Level Mosquito Exposure and anti-gSG6
Response
Information on household-level mosquito exposure was avail-
able for the households of 247 children. At the level of individual
households, exposure to Anopheles females showed a significant
positive correlation with anti-gSG6 IgG level (correlation co-
efficient 0.188, p=0.003) but not with levels of anti-CSP IgG
(correlation coefficient 0.036, p=0.59). When households were
grouped into quintiles according to their relative exposure to
Anopheles (Table 1), there was a statistically significant positive
association between Anopheles exposure in quintiles and anti-gSG6
IgG levels (p=0.001) and prevalence (test for trend in proportions,
p=0.001) (Figure 4). There was no evident association between
individual Anopheles exposure in quintiles and individual CSP
antibody level (p=0.544) or prevalence (test for trend in
proportions p=0.422). Similarly, no significant associations were
observed between Anopheles exposure in quintiles and individual
responses to any blood stage antigen, save MSP-3 for which there
was a significant positive association with antibody level
(p=0.017).
Malaria Incidence and anti-gSG6 and Anti-malaria
Responses
Antibody levels were positively associated with the frequency of
malaria episodes recorded after serum collection for all antigens
except AMA-1 (gSG6 correlation coefficient 0.240, p,0.0001
(Figure 5A); CSP correlation coefficient 0.183, p=0.004; MSP -1
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PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e40170Figure 1. Map of Tanzania showing the north-eastern provinces, and the location of Korogwe district. Sampling in Korogwe district was
conducted in 5 areas, which are marked on the map: Korogwe, Majengo, Magasin, Mnyuzi, and Mandera. Within these areas, our study population
were resident in 15 subvillages. Korogwe consisted of the following subvillages: Kwasemangube (KS), Lwengera (LW) Msambazi (MS) and Masuguru
(MU). Majengo consisted of the following subvillages: Kilole (KI), Majengo (MJ) and Manundu (MA). Magasin consisted of the following subvillages:
Kwagunda (KW) and Maguga (MG). Mnyuzi consisted of the following subvillages: Gereza (GE), Lusanga (LU), Mkwakwani (MK), Mnyuzi (MY) and
Shambakapori (SH). Mandera (MD) was an isolated subvillage.
doi:10.1371/journal.pone.0040170.g001
Figure 2. Mean household Anopheles female count during peak transmission (May) in different subvillages. Numbers of households
sampled for each subvillage, in order of Anopheles exposure, were as follows: MY=45, MS=23, MA=26, MU=21, MJ=29, KS=24, LW=65, LU=61,
MD=45, MK=14, KW=99, SH=13, GE=47, KI=30, MG=91.
doi:10.1371/journal.pone.0040170.g002
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efficient 0.141, p=0.0008; GLURP R1 correlation coefficient
0.126, p=0.003; GLURP R2 correlation coefficient 0.101,
p=0.017 [data not shown]). The prevalence of IgG responses
varied significantly with grouped malaria incidence for gSG6
(p,0.0001), AMA-1 (p=0.004), MSP-1 (p,0.0001) and GLURP
R2 (p=,0.001). No significant variation in seroprevalence of
antibodies to CSP, MSP-3 and GLURP R1 was present between
groups of malaria incidence (Figure 5B). A strong positive
association was observed between grouped malaria incidence
and the prevalence of antibody responses against gSG6, MSP-1
and GLURP R2, while this relationship was present but only
marginally significant for MSP-3 (Figure 5B).
Discussion
In the present study we show that the antibody responses of
young children to the recombinant An. gambiae salivary protein,
gSG6, reflect small scale spatial variation in malaria transmission,
and are strongly associated with malaria risk in an area of
moderate transmission intensity in northern Tanzania where An.
gambiae and An. funestus are the main malaria vectors.
Reactivity to both the peptide and recombinant forms of the
anopheline gSG6 protein has previously been associated with
seasonal or regional patterns in mosquito exposure [45–48,55].
The current study is the first to describe antibody responses to the
recombinant gSG6 protein in relation to village of residence, and
individual level mosquito exposure and malaria incidence. For
this, we utilised a detailed entomological dataset from Korogwe
district, Tanzania, that revealed significant heterogeneity in
Anopheles abundance between and within villages [11]. Despite
generally low reactivity among our infant study population, anti-
gSG6 IgG level and prevalence effectively described varying levels
of exposure to Anopheles between subvillages, corroborating recent
findings from Senegal where gSG6-P1 responses reflected spatial
variation in Anopheles exposure between districts in urban Dakar
[47]. The first studies to assess IgG responses to recombinant
gSG6 were carried out in two rural villages in Burkina Faso, and
revealed .50% seroprevalence in children during the peak
transmission season [48]. The lower responses observed in this
study confirm the lower transmission intensity in the current study
area.
At the level of subvillages, anti-gSG6 antibody responses closely
followed patterns in malaria incidence and community-level
antibody responses to malaria-specific antigens AMA-1 and
MSP-119 [11]. This broad agreement in estimates of malaria
incidence and Anopheles and malaria-specific antibody responses at
subvillage level is unsurprising [45,48,49,55]. Patterns may diverge
when assessed at an individual level, as Anopheles abundance and
biting behaviour may be unevenly distributed between households
[12,21,56] and intense mosquito exposure may not necessarily
mean a high malaria exposure if anophelines are not infected. This
commonly happens at the start of the wet season when mosquitoes
have just emerged and are unlikely to have completed a sporogonic
cycle [57], but mosquito sporozoite rates may also show spatial
variation [11]. Associations between mosquito exposure, malaria
incidence and immune responses are further complicated by the
fact that individuals with the highest malaria exposure will acquire
protective immunity most rapidly and may experience lower
malaria incidence in some settings [58,59]. In general, it is
complex to disentangle markers of exposure from markers of
protection when analysing malaria blood stage antigens. Recent
studies highlight the importance of considering malaria heteroge-
neity when determining the protective effect of antibody responses
on clinical malaria. Initially, counterintuitive observations that
higher blood stage immune responses were associated with
increased malaria incidence [60,61], were explained by adjusting
for heterogeneity in malaria exposure and excluding non-
parasitaemic individuals. This revealed a protective effect among
immune responders, reflecting either true or surrogate humoral
immune mediation [60]. This methodological challenge, first
described by Bejon and colleagues [62,63], has highlighted the
need for markers that capture heterogeneity in malaria exposure
but are not associated with clinical protection [58,60,61]. Markers
of mosquito exposure, as described in this manuscript, may play
this role by identifying those individuals most at risk of malaria.
No clear associations were apparent between Anopheles exposure
at an individual level and antibody responses to any of the malaria-
specific antigens (CSP, AMA-1, MSP-1, MSP-3, GLURP R1,
Table 1. Households grouped into quintiles according to
their relative exposure to Anopheles females during the wet
season entomological survey (May).
Female Anopheles per household
Quintile Households Mean Range
16 40 0
2 44 1.59 1–2
3 45 4.11 3–5
4 45 11.71 6–17
5 49 43.37 17–119
doi:10.1371/journal.pone.0040170.t001
Table 2. Seroprevalence and IgG antibody levels among seropositive children to An. gambiae gSG6, and P. falciparum CSP, AMA-1,
MSP-1, MSP-3, GLURP R1 and GLURP R2.
gSG6 CSP AMA-1 MSP-1 MSP-3 GLURP R1 GLURP R2
Antibody
prevalence %
(n/N)
15 (96/636) 21 (121/575) 2 (9/540) 10 (52/540) 10 (54/566) 3 (16/566) 12 (67/566)
Median OD
(IQR)*
0.290 (0.213–0.575) 0.464 (0.375–0.743) 0.087 (0.066–0.110) 0.210 (0.110–0.329) 22 2
OD optical density.
IQR inter-quartile range (25
th and 75
th percentiles).
n/N proportion of seropositive individuals/total sample size.
*seropositive individuals only.
doi:10.1371/journal.pone.0040170.t002
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with exposure to infected mosquito bites and therefore perhaps
also with overall mosquito biting, but in our analysis did not. This
may be a consequence of the relatively small sample size, and low
EIR [11,21]; in moderate to low endemic areas the proportion of
infected vectors is frequently lower than 1% [15,64,65]. Contrary
to this, individual-level anti-gSG6 responses were strongly
associated with household Anopheles exposure. Interestingly,
mosquito exposure was assessed towards the end of the study,
starting approximately 15 months after the serum sample that was
used for serology was collected. This suggests that heterogeneity in
mosquito exposure is consistent over time in our study area,
supporting the hypothesis of stable hotspots of malaria trans-
mission [10,22].
We previously showed that antibody responses to blood stage
malaria antigens determined in clinic attendees reliably predicted
spatial patterns in malaria incidence in a cohort of children living
in the same area [11]. We here extended these analyses and
showed that an individual’s antibody responses to MSP-1, MSP-3
and GLURP-R2 are all positively associated with subsequent
malaria incidence. The selection of malaria antigens we used in
this study was not intended to be exhaustive, nor did we aim to
identify the malaria antigen with the highest discriminative power
to detect variation in malaria exposure. We chose 4 malaria
antigens to put our findings with gSG6 in an epidemiological
context. Our findings are consistent with previous reports from
areas of heterogeneous exposure where malaria specific antibody
responses as markers of past exposure predict future exposure
[60,61]. Strikingly, in our analyses anti-gSG6 responses also
provided a strong association with malaria incidence, indicating
that malaria heterogeneity is associated with heterogeneous biting
behaviour [12]. Unlike responses to transmission and blood stage
malaria antigens [65,66] responses to gSG6 confer no protection
to malaria, thus avoiding any confounding associations with
immunity and malaria incidence. In such a way, the gSG6 assay
may provide a useful marker for exposure to malaria for use in
clinical studies [58].
Though the sampling framework of the current study was not
designed to evaluate the temporal dynamics of the anti-gSG6
response, there are indications that, as with responses to the
salivary proteins of other haematophagous arthropods, it elicits
short lived antibody responses, reflecting only recent Anopheles
exposure [45,46,48]. As blood-feeding is transitory, and saliva is
only released into the skin during probing with the majority likely
to be re-ingested with the blood meal, this limits the development
of a humoral immune response to mosquito saliva [67–69]. This
short exposure to antigen explains the low anti-gSG6 responses
observed among children from Korogwe. These low level
responses highlight inherent problems in assessing exposure using
an arbitrarily defined cut off for seropositive individuals. Identi-
fying individuals never exposed to malaria is relatively straightfor-
ward but the same cannot be said for individuals never exposed to
Anopheles, a genus which has a very wide geographical distribution.
The nature of mosquito feeding, with the strength of the
correlations observed in our analyses between spatial and in-
dividual level mosquito exposure and antibody OD, supports the
use of antibody level rather than seroprevalence as a finer tool for
assessment of Anopheles exposure intensity.
Conclusions
This is the first report that antibody responses to the
recombinant An. gambiae salivary protein gSG6 in children can
reflect small-scale spatial variation in exposure to anophelines at
village and household level. Importantly, our analysis also provides
the first evidence for a reliable association between malaria
incidence and anti-gSG6 response; a relationship only previously
observed using whole An. gambiae saliva [44]. Caution is required in
extrapolating findings from this study to other age groups because
our analyses were restricted to plasma samples from children aged
9 months and a role of maternal transfer of IgG during
breastfeeding can therefore not be excluded. This limitation of
the current study does not alter our conclusions that these
antibody responses are suitable markers of micro-epidemiological
differences in Anopheles exposure. Potential uses for this assay
Figure 3. Mean anti-gSG6 IgG level per subvillage, plotted against increasing mosquito exposure per subvillage. Anti-gSG6 IgG levels
are given as the log-10 adjusted mean anti-gSG6 OD per subvillage. Mosquito exposure is given as the ascending and sequential mean Anopheles
female count for each of 15 subvillages (x-axis), as in Figure 2. The trend-line from the linear regression is shown as a dashed line (r
2=0.436, p=0.007).
doi:10.1371/journal.pone.0040170.g003
gSG6 Detects Anopheles Exposure and Malaria Risk
PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e40170include establishing Anopheles biting exposure to include indoor and
outdoor biting, controlling for exposure in highly heterogeneous
settings, and as a measure of receptivity to inform programs that
are moving toward elimination where there is a high risk for re-
introduction. However, its utility in low endemic and pre-
elimination settings first needs to be assessed [8]. To this end, it
will be important to establish the assays suitability for use with
scalable antibody sources such as dried filter paper blood-spots.
The identification and analysis of other salivary proteins may also
help increase the sensitivity of the approach in such settings [70].
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Figure 4. IgG responses to gSG6 and P. falciparum antigens, grouped into quintiles of household Anopheles exposure. A. Box plots
showing anti-gSG6 IgG level between groups sorted according to Anopheles exposure in quintiles. Boxes show the median and 25
th/75
th percentiles,
whiskers show the 5
th/95
th percentiles, and outliers are represented by dots. Where outliers were excluded from the graph but not analysis they are
marked with a + and included in parentheses. P values for pairwise comparisons were determined by Mann-Whitney test with Bonferroni correction
(*), and for all groups by Kruskal-Wallis test (**). B. Seroprevalence of anti-gSG6 and anti-P. falciparum IgG antibodies plotted against Anopheles
exposure in quintiles. Error bars indicate 95% confidence intervals (CI). P values were determined by a test for trend in proportions (***).
doi:10.1371/journal.pone.0040170.g004
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